Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) — The “Human Papillomavirus (HPV) Vaccine Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering.
The human papillomavirus (HPV) vaccine market attained a value of nearly USD 5.22 billion in 2023. The market is estimated to grow at a CAGR of 11.60% during the period 2024-2032, reaching USD 14 billion by 2032. This growth is driven by increased awareness of HPV-related diseases and the effectiveness of vaccination programmes, alongside advancements in vaccine technology and government initiatives.
The United States and Europe lead the market due to established healthcare systems and high vaccination rates. Japan and India are emerging markets with significant growth potential, driven by increasing awareness and government initiatives. These regions will drive market expansion through improved healthcare infrastructure and expanded vaccination efforts.
The human papillomavirus (HPV) vaccine market features several key players actively shaping the competitive landscape. Notable companies include Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Bharat Biotech International Limited (BBIL), Inovio Pharmaceuticals Inc., Sanofi SA, Beijing Wantai Biolog Pha Ent Co Ltd, and Walvax Biotechnology Co., Ltd.
These companies engage in activities such as mergers and acquisitions, research initiatives, product introductions, and strategic partnerships to expand their market presence and capabilities. These activities drive innovation and growth within the human papillomavirus (HPV) vaccine market, ensuring continuous improvement and broadening service offerings.
Market Trends
- Increase in Vaccination Programmes
- Technological Integration
- Growing Focus on Male Vaccination
- Public-Private Partnerships
Human Papillomavirus (HPV) Vaccine Market Segmentation
Breakup by Type
Both segments are crucial for market growth, addressing diverse prevention needs. Technological advancements and rising awareness are boosting demand for these vaccines, with polyvalent vaccines gaining popularity for their broader protection. The forecast period will see these segments driving market growth through improved efficacy and expanded immunisation programmes.
Market Breakup by Indication
- Genital Warts
- HPV Associated Cancer
Increased awareness and vaccination programmes drive demand in both segments. HPV-associated cancer vaccines are particularly critical, given the rising incidence of cervical and other cancers. Future growth will be driven by expanded vaccination efforts and new indications, enhancing overall market expansion.
Market Breakup by Rough of Administration
- Intravenous
- Intramuscular
- Others
Intramuscular administration is the most common and effective route, driving most of the market demand. Intravenous and other routes provide alternatives for specific medical needs. Advancements in vaccine delivery methods and increasing vaccination rates support market growth, with intramuscular administration leading due to its widespread acceptance and efficacy.
Market Breakup by Distribution Channel
- Hospital and Retail Pharmacies
- Government Suppliers
- Others
Hospital and retail pharmacies dominate the distribution of human papillomavirus vaccines, driven by accessibility and trust. Government suppliers play a crucial role in mass vaccination programmes, enhancing public health outcomes. Increasing collaboration between public and private sectors, along with expanded distribution networks, will drive market growth across these channels.
Reasons to consider this report:
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the human papillomavirus (HPV) vaccine market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the human papillomavirus (HPV) vaccine market.
- The study maps the leading, as well as the fastest-growing, regional markets, enabling stakeholders to identify key country-level markets within each region.
- Porter’s five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyse the level of competition within the human papillomavirus (HPV) vaccine industry and its attractiveness.
- The competitive landscape section allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2024-2032 |
| Estimated Market Value (USD) in 2024 | $5.8 Billion |
| Forecasted Market Value (USD) by 2032 | $14 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
Key Topics Covered
1 Preface
2 Executive Summary
3 Human Papillomavirus (HPV) Vaccine Market Overview: 8 Major Market
4 Vendor Positioning Analysis
5 Human Papillomavirus (HPV): Disease Overview
6 Patient Profiles
7 Human Papillomavirus (HPV) Vaccine Market Epidemiology Scenario and Forecast – 8 Major Markets
8 Human Papillomavirus (HPV) Vaccine Market Landscape: 8 Major Market
9 Human Papillomavirus (HPV) Vaccine Market Therapy Challenges and Unmet Needs
10 Cost of Therapy
11 Global Human Papillomavirus (HPV) Vaccine: Market Dynamics
12 Human Papillomavirus (HPV) Vaccine Market Segmentation: 8 Major Markets
13 United States Human Papillomavirus (HPV) Vaccine Market (2017-2032)
14 EU-4 and United Kingdom Human Papillomavirus (HPV) Vaccine Market (2017-2032)
15 Japan Human Papillomavirus (HPV) Vaccine Market
16 India Human Papillomavirus (HPV) Vaccine Market
17 Regulatory Framework
18 Patent Analysis
19 Clinical Trial Analysis
20 Grant Analysis
21 Strategic Initiatives
22 Supplier Landscape
23 Human Papillomavirus (HPV) Vaccine Market – Distribution Model
24 Key Opinion Leaders (KOL) Insights
25 Payment Methods
For more information about this report visit https://www.researchandmarkets.com/r/i2mu5m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Human Papillomavirus (HPV) Vaccine Market
